Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 14.28M P/E - EPS this Y - Ern Qtrly Grth -
Income -3.76M Forward P/E - EPS next Y - 50D Avg Chg 48.00%
Sales 98k PEG - EPS past 5Y - 200D Avg Chg 7.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -52.00%
Recommedations - Quick Ratio 0.12 Shares Outstanding 55.61M 52W Low Chg 352.00%
Insider Own 43.80% ROA -85.82% Shares Float 23.75M Beta 0.34
Inst Own 7.34% ROE - Shares Shorted/Prior -/- Price 0.28
Gross Margin 36.74% Profit Margin - Avg. Volume 27,111 Target Price -
Oper. Margin -1,515.63% Earnings Date May 13 Volume 56,775 Change 77.22%
About GUIDED THERAPEUTICS INC

Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.